Azacitidine injection is used to treat patients with French-American-British (FAB) myelodysplastic syndrome (bone marrow issue) subtypes, including refractory anaemia or chronic leukaemia. This medication is also used to treat juvenile myelomonocytic leukaemia (JMML).

Azacitidine is part of a group of medicines called metabolites. It intermeddles with the growth of cancer cells, which are ultimately destroyed. Since the growth of normal body cells might also be affected by azacitidine, other effects will also happen.

Some of these may be severe and must be reported to your doctor. Some effects might not happen for months or years after the medicine is used. The medicine is to be given only by or under the immediate supervision of your doctor.


The product is available in the following dosing forms:

  1. Powder for Suspension